A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2002
12/11/2002	EP0966436B1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
12/11/2002	EP0937064B1 Substituted oximes derivatives useful as neurokinin antagonists
12/11/2002	EP0925294B1 Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels
12/11/2002	EP0923568B1 Novel benzofuran-4-carboxamides
12/11/2002	EP0907632B1 Inhibition of matrix metalloproteases by substituted phenethyl compounds
12/11/2002	EP0863891B1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
12/11/2002	EP0831871B1 Relaxin-like factor and methods and uses thereof
12/11/2002	EP0820289B1 Trapidil for use in the treatment of immuno-modulatorily influencible cases
12/11/2002	EP0805796B1 Cell adhesion inhibitors
12/11/2002	EP0754052B1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound
12/11/2002	EP0723447B1 Use of (2-imidazolin-2-ylamino) quinoxaline derivatives
12/11/2002	CN1384835A Tricycle inhibitors of poly(ADP-ribose) polymerases
12/11/2002	CN1384834A Pyrrolo [2,3-d] pyrimidine nucleoside analoys
12/11/2002	CN1384830A Novel spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases
12/11/2002	CN1384825A Benzylidene thiazolidiones and analogues and their use in treatment of inflammation
12/11/2002	CN1384749A Use of diphophonic acid in treatment of vasculogenesis
12/11/2002	CN1384744A Isoxazole derivatives to be used as phosphodiestesterase VII inhibitors
12/11/2002	CN1384741A Selective COX-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines
12/11/2002	CN1384740A Delayed-action form of administration containing tramadol saccharinate
12/11/2002	CN1384739A Oral pharmaceutical forms of administration with a delayed action
12/11/2002	CN1384738A Transdermal drug delivery devices
12/11/2002	CN1384735A Oral dosage forms
12/11/2002	CN1384733A Dry powder compositions having improved dispersivity
12/11/2002	CN1384713A Dietary food supplement containing natural cyclooxygenase inhibitors
12/11/2002	CN1383882A Ointment for relaxing muscles and joints and promoting blood circulation
12/11/2002	CN1383869A Ointment for healing tranumatic injury fast
12/11/2002	CN1383866A Medicine for treating primary dysmenorrhea and its prepn
12/11/2002	CN1383853A Rheuamtism treating Chinese medicine
12/11/2002	CN1383839A Rheumatism treating plaster and its prepn
12/11/2002	CN1095835C Tricyclo-substituted isohydroxyloxime acid derivative
12/11/2002	CN1095675C Medicinal plaster for curing wind-cold-dampness pathogen and traumatic injury
12/11/2002	CN1095674C Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease
12/11/2002	CN1095661C Anti-inflammatory and analgesic therapeutic composition containing nimesulide for use transdermally and prepn. thereof
12/11/2002	CA2412227A1 Use of a composition consisting of or with a content of at least a dissimilated milk serum
12/11/2002	CA2411165A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof
12/10/2002	US6492536 Glucocorticoids; antiimflammatory and immunosuppressive agents
12/10/2002	US6492516 Pharmaceutically acceptable salts thereof which exhibit utility for the treatment of cytokine mediated diseases such as arthritis.
12/10/2002	US6492497 Specific binding members for TGFbeta1
12/10/2002	US6492496 Antibodies to the receptor protein designated 2F1
12/10/2002	US6492428 Macrophage migration inhibitory factor (mif); substituted iminoquinone or orthoquinone ring systems
12/10/2002	US6492425 Inhibitors of transcription factor-NF-κB
12/10/2002	US6492422 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
12/10/2002	US6492416 4,5-diaryl-3(2H)-furanone derivatives as cyclooxygenase-2 inhibitors
12/10/2002	US6492411 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
12/10/2002	US6492409 Such as 5-(1-(3-aminopropyl)-3-indolyl)-1-(3-indolyl)-1,3-dihydroimidazol-2-one; protein kinase c inhibitors; high solubility; reduced color; treating inflammatory and/or immunological disorders
12/10/2002	US6492408 Peptidomimetic inhibitors of intercellular adhesion molecules binding to leukointegrins, such as lfa-1 and mac-1
12/10/2002	US6492403 Methods of treating C1s-mediated diseases and conditions and compositions thereof
12/10/2002	US6492393 Compounds useful as anti-inflammatory agents
12/10/2002	US6492390 Treating cyclooxygenase-2 mediated disorders.
12/10/2002	US6492379 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
12/10/2002	US6492372 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
12/10/2002	US6492367 Sulfamato hydroxamic acid metalloprotease inhibitor
12/10/2002	US6492364 Triazolo and derivatives as chemokine inhibitors
12/10/2002	US6492362 Compounds and compositions as cathepsin S inhibitors
12/10/2002	US6492360 Phthalazine derivatives phosphodiesterase 4 inhibitors
12/10/2002	US6492355 Adamantane derivatives
12/10/2002	US6492349 Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
12/10/2002	US6492348 Adenosine derivatives
12/10/2002	US6492331 NL8 tie ligands homologues
12/10/2002	US6492129 Fragments comprising the n-terminal region of connective tissue growth factor (ctgf); screening for inhibitors or stimulators of ctgf
12/10/2002	US6491943 Method for treating an allergic or inflammatory disease
12/10/2002	US6491933 Personal care articles comprising hotmelt compositions
12/10/2002	US6491915 Anti-CCR2 antibodies and methods of use therefor
12/10/2002	US6491893 Compounds for targeting and imaging infection and inflammation
12/10/2002	CA2208792C Substituted indazole derivatives
12/08/2002	CA2817619A1 Methods of administering anti-tnf.alpha. antibodies
12/08/2002	CA2385745A1 Methods of administering anti-tnf.alpha. antibodies
12/06/2002	WO2002039982A1 Oral formulations for localized colonic release and the method of preparation thereof
12/06/2002	CA2411045A1 Oral formulations for localized colonic release and the method of preparation thereof
12/05/2002	WO2002097120A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
12/05/2002	WO2002097060A2 Carbohydrate-associated proteins
12/05/2002	WO2002097046A2 B7 related protein-2 molecules and uses thereof
12/05/2002	WO2002097044A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities
12/05/2002	WO2002097035A2 Secreted proteins
12/05/2002	WO2002097032A2 Proteins associated with cell growth, differentiation, and death
12/05/2002	WO2002097030A2 Peptides derived from neural thread proteins and their medical use
12/05/2002	WO2002096952A2 Conjugate of a transport protein and a protein for modulation of notch signalling
12/05/2002	WO2002096951A1 Molecules for disease detection and treatment
12/05/2002	WO2002096943A1 Stat6-activating genes
12/05/2002	WO2002096927A2 Ribozyme based treatment of female reproductive diseases
12/05/2002	WO2002096921A1 Novel glucose derivative inducing apoptosis, process for producing the same, and use thereof as medicine
12/05/2002	WO2002096913A1 Substituted di(hydroxy/alkoxy)silicon phthalocyanines and their uses
12/05/2002	WO2002096911A1 Novel heteroaryl-diazabicyclo-alkanes as cns-modulators
12/05/2002	WO2002096909A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl) -methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors
12/05/2002	WO2002096904A1 Novel heterocyclic derivatives and medicinal use thereof
12/05/2002	WO2002096896A1 Biologically active methylene blue derivatives
12/05/2002	WO2002096893A1 Process for preparing a thialzole ppar-ligand and polymorphs thereof
12/05/2002	WO2002096892A1 Oxadiazole derivative compounds and drugs containing these compounds as the active ingredient
12/05/2002	WO2002096887A1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
12/05/2002	WO2002096886A1 Pyrimidine derivatives
12/05/2002	WO2002096885A1 Pyrimidine derivatives useful as selective cox-2 inhibitors
12/05/2002	WO2002096883A1 Tricyclic compounds useful as angiotensin ii agonists
12/05/2002	WO2002096879A1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
12/05/2002	WO2002096877A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis
12/05/2002	WO2002096876A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002	WO2002096875A1 4-hydroxpiperidine derivative with analgetic activity
12/05/2002	WO2002096867A2 Inhibitors of protein kinase for the treatment of disease
12/05/2002	WO2002096866A2 Thiolalkyl benzoic acid derivatives
12/05/2002	WO2002096864A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
12/05/2002	WO2002096516A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease

1 ... 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 ... 1272